CEFOXITINE PANPHARMA 1 g, poudre pour solution injectable (IV)

( ARTG ) Cefoxitin Sodium for Injection is indicated for the treatment of the following infections when due to susceptible organisms (see Microbiology): peritonitis and other intra-abdominal and intra-pelvic infections, female genital tract infections, septicaemia, endocarditis, urinary tract infections, respiratory tract infections, bone and joint infections, and skin and skin structure infections.‍‍‍‍‍‍​​​‍​​​​​​ Cefoxitin Sodium for Injection has a high degree of stability against beta-lactamase and therefore effective against beta-lactamase producing organisms resistant to penicillins or cephalosporins. It can also be used in mixed infections provided that the organisms are sensitive to it. Cefoxitin Sodium can be used as adjunctive therapy in the surgical treatment of infections including abscesses, infection complicating hollow viscus perforations, cutaneous infections and infections of serous surfaces whether caused by aerobes, mixed aerobes and anaerobes or anaerobes. Cefoxitin Sodium for Injection is also indicated for the prevention of post-operative infections associated with certain surgical procedures of the gastrointestinal, biliary and genital tracts.